Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice C Wei

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Annals of Surgery|January 9, 2025
Clinicopathological Characteristics and Long-Term Outcomes of Cystic vs. Solid Pancreatic Neuroendocrine Tumors: A Multi-Institutional Experience with 1727 PatientsMarco Ventin, Shahrzad Arya, Giulia Cattaneo, et al.
Annals of Surgical Oncology|December 10, 2024
Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal AdenocarcinomasEllis L Eikenboom, Naaz Nasar, Kenneth Seier, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Frontiers in Oncology|March 9, 2026
Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot studyEllis L Eikenboom, Joséphine Magnin, Remo Alessandris, et al.
The British Journal of Surgery|February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort studyEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
BMJ Open|June 22, 2022
Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adultsDuminda N Wijeysundera, Shabbir M H Alibhai, Karim S Ladha, et al.
JAMA Oncology|September 1, 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical TrialThierry Conroy, Florence Castan, Anthony Lopez, et al.
Annals of Surgical Oncology|August 28, 2023
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver MetastasesFloris S Verheij, Koert F D Kuhlmann, Danielle R Silliman, et al.
Annals of Surgery|May 22, 2023
Risk Factors for Progression in Patients Undergoing Surveillance for Pancreatic CystsMisha T Armstrong, Lily V Saadat, Joanne F Chou, et al.
Annals of Surgical Oncology|October 5, 2024
Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After ChemotherapyGeorgios Karagkounis, Natally Horvat, Sofia Danilova, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Annals of Surgery|January 9, 2025
Clinicopathological Characteristics and Long-Term Outcomes of Cystic vs. Solid Pancreatic Neuroendocrine Tumors: A Multi-Institutional Experience with 1727 PatientsMarco Ventin, Shahrzad Arya, Giulia Cattaneo, et al.
Annals of Surgical Oncology|December 10, 2024
Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal AdenocarcinomasEllis L Eikenboom, Naaz Nasar, Kenneth Seier, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
Frontiers in Oncology|March 9, 2026
Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot studyEllis L Eikenboom, Joséphine Magnin, Remo Alessandris, et al.
The British Journal of Surgery|February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort studyEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
BMJ Open|June 22, 2022
Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adultsDuminda N Wijeysundera, Shabbir M H Alibhai, Karim S Ladha, et al.
JAMA Oncology|September 1, 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical TrialThierry Conroy, Florence Castan, Anthony Lopez, et al.
Annals of Surgical Oncology|August 28, 2023
Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemotherapy-Naive Patients with Unresectable Colorectal Liver MetastasesFloris S Verheij, Koert F D Kuhlmann, Danielle R Silliman, et al.
Annals of Surgery|May 22, 2023
Risk Factors for Progression in Patients Undergoing Surveillance for Pancreatic CystsMisha T Armstrong, Lily V Saadat, Joanne F Chou, et al.
Annals of Surgical Oncology|October 5, 2024
Computed Tomography-Based Radiomics with Machine Learning Outperforms Radiologist Assessment in Estimating Colorectal Liver Metastases Pathologic Response After ChemotherapyGeorgios Karagkounis, Natally Horvat, Sofia Danilova, et al.
Pageof 18